AppLovin Corporation (NASDAQ:APP) will release earnings results for the third quarter, after the closing bell on Wednesday, Nov. 5.Analysts expect the Palo Alto, California-based company to report quarterly earnings at $2.39 per share, up from $1.25 per share in the year-ago period. The consensus estimate for AppLovin's quarterly revenue is $1.34 billion, compared to $1.2 billion a year earlier, according to data from Benzinga Pro.On Aug. 6, Applovin posted upbeat earnings for the second quarter.AppLovin sh ...

Johnson Controls International plc (NYSE:JCI) will release earnings results for the fourth quarter before the opening bell on Wednesday, Nov. 5.Analysts expect the Cork, Ireland-based company to report quarterly earnings at $1.20 per share, down from $1.28 per share in the year-ago period. The consensus estimate for Johnson Controls' quarterly revenue is $6.33 billion, compared to $7.39 billion a year earlier, according to Benzinga Pro.On Sept. 24, Johnson Controls announced the appointment of Todd Grabowsk ...

Super Micro Computer, Inc. (NASDAQ:SMCI) will release earnings results for the first quarter, after the closing bell on Tuesday, Nov. 4.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at 39 cents per share, down from 74 cents per share in the year-ago period. The consensus estimate for Super Micro Computer's quarterly revenue is $5.8 billion, compared to $5.94 billion a year earlier, according to data from Benzinga Pro.On Oct. 29, Super Micro Computer announced the creat ...

Pfizer Inc. (NYSE:PFE) will release earnings results for the third quarter before the opening bell on Tuesday, Nov. 4.Analysts expect the health care company to report quarterly earnings at 64 cents per share, down from $1.06 per share in the year-ago period. The consensus estimate for Pfizer’s quarterly revenue is $16.52 billion, down from $17.7 billion a year earlier, according to Benzinga Pro.On Friday, Pfizer filed a lawsuit against Metsera, Inc. (NASDAQ:MTSR), its Board of Directors, and Novo Nordisk ( ...

Lear Corporation (NYSE:LEA) reported upbeat earnings for the third quarter on Friday.The company posted quarterly earnings of $2.79 per share which beat the analyst consensus estimate of $2.73 per share. The company reported quarterly sales of $5.680 billion which beat the analyst consensus estimate of $5.600 billion.Lear raised its FY2025 sales guidance from $22.470 billion-$23.070 billion to $22.850 billion-$23.150 billion.“Lear continued its solid momentum in the third quarter, delivering one of the high ...

Lear Corporation (NYSE:LEA) reported upbeat earnings for the third quarter on Friday.The company posted quarterly earnings of $2.79 per share which beat the analyst consensus estimate of $2.73 per share. The company reported quarterly sales of $5.680 billion which beat the analyst consensus estimate of $5.600 billion.Lear raised its FY2025 sales guidance from $22.470 billion-$23.070 billion to $22.850 billion-$23.150 billion.“Lear continued its solid momentum in the third quarter, delivering one of the high ...

nVent Electric plc (NYSE:NVT) reported its third-quarter results on Friday that topped street estimates.The company reported adjusted earnings of 91 cents per share, up 44% from the prior year period, surpassing analysts' expectations of 88 cents.Net sales climbed to $1.05 billion, up 35% from a year earlier and ahead of estimates of $1.01 billion, while organic sales growth was 16% for the quarter. The company's adjusted operating income rose 27% to $213 million.nVent Electric raised its full-year 2025 out ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, Nov. 3.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from $4.38 per share in the year-ago period. The consensus estimate for Vertex Pharmaceuticals' quarterly revenue is $3.06 billion, compared to $2.77 billion a year earlier, according to data from Benzinga Pro.On Aug. 4, Vertex Pharmaceuticals posted better-th ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, Nov. 3.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from $4.38 per share in the year-ago period. The consensus estimate for Vertex Pharmaceuticals' quarterly revenue is $3.06 billion, compared to $2.77 billion a year earlier, according to data from Benzinga Pro.On Aug. 4, Vertex Pharmaceuticals posted better-th ...

财报预期 - 公司将于10月31日盘前公布第三季度财报 [1] - 市场预期季度每股收益为9.29美元 较去年同期的8.82美元有所增长 [1] - 市场预期季度营收为137.5亿美元 略低于去年同期的137.9亿美元 [1] 近期业绩与股价表现 - 第二季度营收同比增长0.6%至137.7亿美元 超出市场预期的137.6亿美元 [2] - 公司股价在财报公布前下跌4.4% 收于230.92美元 [2] 分析师评级与目标价 - Citigroup分析师给予买入评级 目标价325美元 准确率74% [5] - Goldman Sachs分析师给予卖出评级 目标价223美元 准确率75% [5] - Wells Fargo分析师给予持有评级 目标价300美元 准确率65% [5] - UBS分析师维持中性评级 但将目标价从425美元下调至355美元 准确率76% [5] - Morgan Stanley分析师维持持有评级 并将目标价从385美元上调至415美元 准确率74% [5]